Author:
Keeney Matthew E.,Bhagavathi Sharathkumar
Publisher
Springer International Publishing
Reference17 articles.
1. Swerdlow SH, Campo E, Harris NL, Jaffe E, Pileri S, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. (revised 4th edition). Lyon: IARC; 2017.
2. Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms. JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia. 2010;24:1128–38.
3. Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368:1381–90.
4. Tefferi A, Elliott M, Pardanani A. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice. Curr Opin Hematol. 2015;22:171–6.
5. Ismail SI, Naffa RG, Yousef AF, Ghanim MT. Incidence of bcr-abl fusion transcripts in healthy individuals. Mol Med Rep. 2014;9(4):1271–76